HSPA1A and breast neoplasm: In that study [238], an ability of the promiscuous HSP70-derived epitope peptide to induce the antitumor response has been demonstrated only for hepatocellular carcinoma but this peptide may also act against breast tumors expressing the respective HLA-A subclasses.